In 2018, the industry can expect risk-based everything, cloud-first strategies, and a focus on modernization as companies look to stand out amongst the competition, say Veeva Systems execs.
Veeva has announced two new products and a series of new hires across its product management team after nearly doubling its customers over the past year.
As part of the company’s “site-centric” approach, inVentiv has expanded its relationship with the Society of Clinical Research Sites (SCRS) to elevate the “voice” of clinical sites.
Recipharm has completed the acquisition of a majority stake in India’s Nitin Lifesciences in a deal the Swedish contractor says strengthens its presence in an important market.
Recipharm has raised SEK276m ($32m) to part finance the acquisition of a majority stake in Indian CMO Nitin Life Sciences that it announced in October.
Charles River is set to acquire WIL Research for approximately $585 million in cash, further enhancing the company’s capabilities to include contract development and manufacturing (CDMO).
Hemispherx Biopharma has signed extended US distribution agreements as part of efforts to relaunch Alferon N Injection, a genital wart treatment it pulled in 2008 after production costs soared.
Recipharm will acquire a facility and add technologies including spray granulation and spray coating as part of a “truly strategic” collaboration with France-based Flamel Technologies.
Patient recruitment is “the major bottleneck” in clinical development, an Industry Standard Research report says, but though it predicts a drive to ‘push’ patients into trials, industry disagrees.
In an exclusive interview, Patheon Executive Mike Lehmann talks DSM integration, further growth and how consolidation amongst CMOs may be driving strategic alliances with pharma.
Chiltern has a new Director of Global Pharmacovigilance and there's an appointment at DSM in this week's lowdown on the outsourcing industry's movers and shakers.
Parexel will dish out $450,000 a year for new Senior VP Ingo Bank, and there's a double recruitment for DPT Laboratories - it's Outsourcing-Pharma.com's People column.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Alkermes, ICON and NextPharma.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Sanofi and Boehringer Ingelheim.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Mylan, Sigma-Tau and Immunocore.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Sanofi, Bausch + Lomb and BASF.
The Kansas Bioscience Authority has awarded a $400,000 grant to the CRO PRA to create a new program to attract recent college graduates into the clinical research and CRO industries.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Catalent, Hospira and Eisai.
As it inks a major commercial supply agreement, Unilife says its EZMix dual-chamber syringe will significantly cut reconstitution steps in combination therapy delivery.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from PPD, Chiltern and Premier Research.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from bioTheranostics, Arcadia and INC Research.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Catalent, Dow and Agere Pharmaceuticals.
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news from Merck, BASF and Tenex.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Novella, Pantheon and Synteract.
in-PharmaTechnologist.com presents its latest round-up of movers and shakers in the world of pharmaceuticals, including news from Cipla, Dr. Reddy’s and Immunogen.
An industry consortium has asked the USP to delay new elemental impurities chapters on concerns that lack of harmonization with ICH Q3D will create compliance difficulties, shortages and additional costs.
Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceuticals, including news from Chiltern, Thermo Fisher and Penn Pharma.
Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharma, including news from Icon, Althea and PSKW.
in-PharmaTechnologist presents its weekly round-up of the latest appointments in the pharmaceutical industry, including news from Silence Therapeutics, Accorda, and Hospira.
Outsourcing-Pharma presents its latest round-up of the latest chops and changes in the pharmaceutical industry, with news from Clinipace, PHT, and Catabis.
Outsourcing-Pharma presents a round-up of the latest appointments in the pharmaceutical outsourcing business, with news from Creabilis, Daiichi Sankyo, and ACM.
US CRO Charles River Laboratories (CRL) has rejigged its upper management as part of a business realignment that unifies its regional research model and preclinical development businesses.
Outsourcing-Pharma presents a round-up of the latest appointments in the pharmaceutical outsourcing business, with news from Icon, PPD, Addex, and Cangene.
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, will news from Paragon, Pantheon, Amgen and PharmaNet.
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, which news from Aesica, SCM, Phlexglobal and Celerion.
